Skip to main content
. 2018 Oct 18;25(1):1846–1857. doi: 10.1080/10717544.2018.1486472

Figure 5.

Figure 5.

In vivo anti-tumor effect of sPEG/HA/CSO-SS-Hex/Fe3O4/GA. (A) Change of tumor volume in 4T1 cell-bearing mice after intravenous injection of different formulations. The two groups of GA and sPEG/HA/CSO-SS-Hex/Fe3O4/GA all showed the extremely significant difference (p < 0.01) vs. saline control. (B) Change of body weight in 4T1-bearing mice during the study. (C) Images of excised tumors of all groups at the end of study. (11 days post the initiation of treatment). Points are presented as mean ± SEM (n = 6).